Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NAGE
NAGE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NAGE News
Niagen Bioscience Increases Share Repurchase Program to $20 Million
Mar 19 2026
seekingalpha
Niagen Bioscience Expands Share Repurchase Program to $20 Million
Mar 19 2026
Newsfilter
Niagen Bioscience to Participate in ROTH Conference
Mar 18 2026
Newsfilter
Niagen Bioscience Surpasses 300 Research Agreements, Strengthening NAD+ Research
Mar 17 2026
Newsfilter
Niagen® Expands into Skincare Market with Innovative Product Launch
Mar 10 2026
Newsfilter
Niagen Bioscience Reports Q4 and Full-Year 2025 Financial Results
Mar 06 2026
NASDAQ.COM
Veeva Systems Reports Strong Q4 Results and Raises FY27 Guidance
Mar 05 2026
Benzinga
Niagen Bioscience Shares Surge 18.41% After Strong Financials
Mar 05 2026
Benzinga
Niagen Bioscience Q4 2025 Earnings Highlights
Mar 05 2026
seekingalpha
U.S. and Ecuador Jointly Target Drug Traffickers
Mar 05 2026
seekingalpha
Niagen Bioscience Reports Strong 2025 Earnings Performance
Mar 04 2026
Yahoo Finance
Niagen Bioscience Reports Strong Financial Growth
Mar 04 2026
Benzinga
Niagen Bioscience Q4 Earnings Exceed Expectations
Mar 04 2026
seekingalpha
Niagen Bioscience to Announce Q4 Earnings on March 4
Mar 03 2026
seekingalpha
Niagen Bioscience Secures New Patent for IV and Injectable NR Formulations
Feb 25 2026
Businesswire
Niagen Bioscience Secures New Patent for NAD+ Delivery
Feb 25 2026
Newsfilter
Show More News
